A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors - Concepedia

Concepedia

Publication | Closed Access

A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors

34

Citations

41

References

2011

Year

Alejandro D. Ricart, Edward Ashton, Matthew M. Cooney, John Sarantopoulos, Joanna M. Brell, Maria Feldman, Kale E. Ruby, Kazuko Matsuda, Mark S. Munsey, Gerardo Medina,

Cancer Chemotherapy and Pharmacology

OncologyMedicinePathologyAdvanced Solid TumorsNovel Vascular-disrupting AgentVascular BiologyTumor TargetingAnti-cancer AgentCancer TreatmentPharmacologyTumor MicroenvironmentCancer Research

References

	Year	Citations

Page 1

Page 1